Retinoic acid therapy served by ligands cross linking and masking CD38

Leukemia Research

Volumn 31, Issue 4, 2007, Pages 423-425

  Yen, Andrew ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; CD31 ANTIGEN; CD38 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE; RETINOIC ACID; SEMAPHORIN;

CALCIUM TRANSPORT; CELL ADHESION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CROSS LINKING; CYTOKINE RELEASE; EDITORIAL; HUMAN; LEUKEMIA CELL LINE; MITOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RETINOIC ACID SYNDROME; SIGNAL TRANSDUCTION; TARGET CELL;

ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LIGANDS; RECEPTORS, RETINOIC ACID; TRETINOIN;

EID: 33846672898     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.07.003     Document Type: Editorial

References (20)

1. Gao Y., Camacho L.H., and Mehta K. Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-γ/interleukin-1β-dependent apoptosis of endothelial cells: Implications in the etiology of retinoic acid syndrome. Leuk Res 31 (2007) 455-463
2. Kishimoto H., Hoshino S., Ohori M., Kontani K., Nishin H., Suszawa M., et al. Molecular mechanisms of human CD38 gene expression by retinoic acid. J Biol Chem 273 (1998) 15429-15434
3. Lamkin T.J., Chin V., Varvayanis S., Smith J.L., Sramkoski R.M., Jacobberger J.W., et al. Retinoic acid-induced CD38 expression in HL-60 myeloblastic leukemia cells regulates cell differentiation or viability depending on expression levels. J Cell Biochem 97 (2006) 1328-1338
4. Lee H.C. Unified mechanism of enzymatic synthesis of two calcium messengers: Cyclic ADP-ribose and NAADP. J Biol Chem 380 (1999) 785-793
5. Deaglio S., Mehta K., and Malavasi F. A (r)evolutionary story of enzymes and receptors. Leukemia Res 25 (2001) 1-12
6. Zabiaur M., Fernandez O., Ferrero E., Salmerón J., Malissen B., Malavasi F., et al. CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/Protein kinase B and Erk activation in the absence of the CD3-ζ immune receptor tyrosine-based activation motif. J Biol Chem 277 (2002) 13-22
7. Yen A., Roberson M.S., Varvayanis S., and Lee A.T. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 58 (1998) 3163-3172
8. Di Noto R., Lo Pardo C., Schiavone E.M., Ferrara F., Manzo C., Vacca C., et al. All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia. Leuk Lymphoma 21 (1996) 201-209
9. Deaglio S., Mallone R., Baj G., Donati D., Giraudo G., Corno F., et al. Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway. FASEB J 15 (2001) 580-582
10. Deaglio S., Vaisitti T., Bergui L., Bonello L., Horenstein A.L., Tamagnone L., et al. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood 105 (2005) 3042-3050
11. Konopleva M., Estrov Z., Zhao S., Andreeff M., and Mehta K. Ligation of cell surface CD38 protein with agonistic monocloncal antibody induces a cell growth signal in myeloid leukemia cells. J Immunol 161 (1998) 4702-4708
12. Zocchi E., Daga A., Usai C., Franco L., Guida L., Bruzzone S., et al. Expression of CD38 increases intracellular calcium concentration and reduced doubling time in HeLa and 3T3 cells. J Biol Chem 273 (1998) 8017-8024
13. Kumagai M.A., Coustan-Smith E., Murray D.J., Silvennoinen O., Murti K.G., Evans W.E., et al. Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med 181 (1995) 1101-1110
14. Todisco E., Suzuki T., Srivannaboon K., Coustan-Smith E., Raimondi S.C., Behm F.G., et al. CD38 ligation inhibits normal and leukemic myelopoiesis. Blood 95 (2000) 535-542
15. Cho Y.S., Han M.K., Choi Y.B., Yun Y., Shin J., and Kim U.H. Direct interaction of the CD38 cytoplasmic tail and the Lck SH2 domain CD38 transduces T cell activation signals through associated Lck. J Biol Chem 275 (2000) 1685-1690
16. Wightman J., Roberson M.S., Lamkin T.J., Varvayanis S., and Yen A. Retinoic acid-induced growth arrest and differentiation: retinoic acid up-regulates CD32 (FcγRII) expression whose ectopic expression retards the cell cycle. Mol Cancer Ther 1 (2002) 493-506
17. Kontani K., Kikimoto I., Nishina H., Hoshino S.-I., Hazeki O., Kanaho Y., et al. Tyrosine phosphorylation of the c-cbl proto-oncogene product mediated by cell surface antigen CD38 in HL-60 cells. J Biol Chem 271 (1996) 1534-1537
18. Battle T.E., Roberson M.S., Zhang T., Varvayanis S., and Yen A. Retinoic acid-induced BLR1 expression requires RARα, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation. Eur J Cell Biol 80 (2001) 59-67
19. Yen A., Sturgill R., Varvayanis S., and Chern R. FMS (CSF-1 receptor) prolongs cell cycle, promotes retinoic acid induced hypophosphorylation of RB protein G1 arrest and cell differentiation. Exp Cell Res 229 (1996) 111-125
20. Riccioni R., Saulle E., Militi S., Sposi N.M., Gualtiero M., Mauro N., et al. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukaemia. Leukemia 17 (2003) 98-113